GENSIGHT BIOLOGICS SA by Gensight Biologics SA (GSGTF) Stock Price, Quote, News & History

GSGTFOTCEM

Trade with Public

$0.1901

At close: Jun 12, 5:00 PM EST

OverviewNews Short Interest

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.19 - 0.19

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Gensight Biologics SA News

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14)

Shanthi Rexaline

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-9.17M

Investing Cash Flow (TTM)

180.00K

Financing Cash Flow (TTM)

8.94M

Free Cash Flow (TTM)

-9.17M

Capital Expenditure (TTM)

-4.00K

Net Change in Cash (TTM)

-53.00K

Valuation Metrics

Enterprise Value

$52.46M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$12.51M

LT Debt

$9.22M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$497.00K

Total Cash

$2.42M

Debt to Equity

Issuance of Debt (TTM)

-$497.00K

Repayment of Debt (TTM)

-$497.00K

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.19 - 0.19

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Biotechnology

Gensight Biologics SA is a clinical-stage biopharma company focused on developing and commercializing gene therapies for retinal neurodegenerative diseases and central nervous system disorders. The company's pipeline leverages two core technology pla...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy GENSIGHT BIOLOGICS SA by Gensight Biologics SA (GSGTF) stock?

You can purchase shares of GENSIGHT BIOLOGICS SA by Gensight Biologics SA (OTCEM:GSGTF) through any online brokerage.

View our list of the best stock brokerages

Who are GENSIGHT BIOLOGICS SA by Gensight Biologics SA (GSGTF) competitors?

There are no as such competitors for GENSIGHT BIOLOGICS SA by Gensight Biologics SA.

What is the forecast, or price target, for GENSIGHT BIOLOGICS SA by Gensight Biologics SA (GSGTF) stock?

There is no analysis for GENSIGHT BIOLOGICS SA by Gensight Biologics SA to provide a consensus price target.

What is the current price for GENSIGHT BIOLOGICS SA by Gensight Biologics SA (GSGTF)?

The stock price for GENSIGHT BIOLOGICS SA by Gensight Biologics SA (OTCEM: GSGTF) is $0.1901 last updated August 18, 2025 at 12:51 PM EDT.

Does GENSIGHT BIOLOGICS SA by Gensight Biologics SA (GSGTF) pay a dividend?

There are no upcoming dividends for GENSIGHT BIOLOGICS SA by Gensight Biologics SA.

When is GENSIGHT BIOLOGICS SA by Gensight Biologics SA (OTCEM:GSGTF) reporting earnings?

GENSIGHT BIOLOGICS SA by Gensight Biologics SA does not have any upcoming earnings scheduled.

Is GENSIGHT BIOLOGICS SA by Gensight Biologics SA (GSGTF) going to split?

There is no upcoming split for GENSIGHT BIOLOGICS SA by Gensight Biologics SA.

What sector and industry does GENSIGHT BIOLOGICS SA by Gensight Biologics SA (GSGTF) operate in?

GENSIGHT BIOLOGICS SA by Gensight Biologics SA is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Benzinga

Benzinga